Provided by Tiger Trade Technology Pte. Ltd.

PTC Therapeutics

70.70
+0.79501.14%
Volume:2.18M
Turnover:151.98M
Market Cap:5.68B
PE:7.91
High:72.28
Open:68.45
Low:64.67
Close:69.90
52wk High:87.50
52wk Low:35.95
Shares:80.29M
Float Shares:65.01M
Volume Ratio:2.39
T/O Rate:3.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):8.94
EPS(LYR):-4.7276
ROE:-7740.12%
ROA:25.70%
PB:-36.44
PE(LYR):-14.95

Loading ...

Stock Track | PTC Therapeutics Plummets 5.14% Intraday After Earnings Miss and RBC Price Target Cut

Stock Track
·
Yesterday

RBC Cuts Price Target on PTC Therapeutics to $82 From $87, Keeps Sector Perform Rating

MT Newswires Live
·
Yesterday

PTC Therapeutics Is Maintained at Buy by B of A Securities

Dow Jones
·
Yesterday

RBC Capital Keeps Their Hold Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Yesterday

Bank of America Securities Reaffirms Their Buy Rating on PTC Therapeutics (PTCT)

TIPRANKS
·
Yesterday

Sephience-Led Growth, Global Expansion, and Robust Pipeline Underpin Buy Rating on PTC Therapeutics

TIPRANKS
·
Yesterday

PTC Therapeutics: Sephience Uptake, Advancing Pipeline, and Strengthening Financials Support Buy Rating

TIPRANKS
·
Yesterday

U.S. RESEARCH ROUNDUP-Dropbox, Etsy, Zscaler

Reuters
·
Yesterday

PTC Therapeutics Inc : RBC Cuts Target Price to $82 From $87

THOMSON REUTERS
·
Yesterday

PTC Therapeutics Exec. VP and CLO Mark Elliott Boulding Disposes of Common Shares

Reuters
·
Yesterday

Earnings Flash (PTCT) PTC Therapeutics Posts Q4 Loss $1.67 per Share

MT Newswires Live
·
Yesterday

PTC Therapeutics Inc. Publishes Corporate Presentation Highlighting Sephience Launch and Pipeline Progress

Reuters
·
Yesterday

PTC Therapeutics reports Q4 EPS ($1.67), consensus (41c)

TIPRANKS
·
Yesterday

PTC Therapeutics sees 2026 product revenue up 19%-36%to $700M-$800M

TIPRANKS
·
Yesterday

PTC Therapeutics Q4 EPS $(1.67) Misses $0.07 Estimate, Sales $164.677M Miss $276.665M Estimate

Benzinga
·
Yesterday

PTC Therapeutics posts FY 2025 total revenues of USD 1.73B**2.15x**

Reuters
·
Yesterday

BRIEF-PTC Therapeutics Q4 Net Income USD -134.965 Million

Reuters
·
Yesterday

PTC Therapeutics Faces Translarna Setback While Valuation Signals Potential Upside

Simply Wall St.
·
Feb 18

TD Cowen Remains a Hold on PTC Therapeutics (PTCT)

TIPRANKS
·
Feb 13

BUZZ-PTC Therapeutics falls after withdrawing muscle disorder drug marketing application

Reuters
·
Feb 13